124 related articles for article (PubMed ID: 21117999)
1. Evaluation of an in vitro telomeric repeat amplification protocol assay to detect telomerase activity in canine urine.
McCleary-Wheeler AL; Williams LE; Hess PR; Suter SE
Am J Vet Res; 2010 Dec; 71(12):1468-74. PubMed ID: 21117999
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer.
Dalbagni G; Han W; Zhang ZF; Cordon-Cardo C; Saigo P; Fair WR; Herr H; Kim N; Moore MA
Clin Cancer Res; 1997 Sep; 3(9):1593-8. PubMed ID: 9815848
[TBL] [Abstract][Full Text] [Related]
3. Detection of telomerase activity in cultured cells and tumor tissue of lung carcinoma by modified telomeric repeat amplification protocol.
Liu Y; Wu BQ; Zhong HH; Xu ML; Fang WG
Pathol Int; 2010 May; 60(5):386-94. PubMed ID: 20518889
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of an assay for detecting telomerase activity in neoplastic tissues of dogs.
Biller BJ; Kitchell BE; Cadile CD
Am J Vet Res; 1998 Dec; 59(12):1526-9. PubMed ID: 9858400
[TBL] [Abstract][Full Text] [Related]
5. Nonradioactive detection of telomerase activity using the telomeric repeat amplification protocol.
Herbert BS; Hochreiter AE; Wright WE; Shay JW
Nat Protoc; 2006; 1(3):1583-90. PubMed ID: 17406450
[TBL] [Abstract][Full Text] [Related]
6. [Detection of human telomerase activity by telomerase TRAP-ELISA assay].
Wei L; Guo Y; Yan Z
Zhonghua Zhong Liu Za Zhi; 1998 Jul; 20(4):264-6. PubMed ID: 10920979
[TBL] [Abstract][Full Text] [Related]
7. Microarray TRAP--a high-throughput assay to quantitate telomerase activity.
Heller-Uszynska K; Kilian A
Biochem Biophys Res Commun; 2004 Oct; 323(2):465-72. PubMed ID: 15369774
[TBL] [Abstract][Full Text] [Related]
8. Telomerase: a potential marker of bladder transitional cell carcinoma in bladder washes.
Lee DH; Yang SC; Hong SJ; Chung BH; Kim IY
Clin Cancer Res; 1998 Mar; 4(3):535-8. PubMed ID: 9533519
[TBL] [Abstract][Full Text] [Related]
9. Detection of telomerase activity in high concentration of cell lysates using primer-modified gold nanoparticles.
Xiao Y; Dane KY; Uzawa T; Csordas A; Qian J; Soh HT; Daugherty PS; Lagally ET; Heeger AJ; Plaxco KW
J Am Chem Soc; 2010 Nov; 132(43):15299-307. PubMed ID: 20932008
[TBL] [Abstract][Full Text] [Related]
10. Comparison of human telomerase RNA and telomerase activity in urine for diagnosis of bladder cancer.
Müller M; Krause H; Heicappell R; Tischendorf J; Shay JW; Miller K
Clin Cancer Res; 1998 Aug; 4(8):1949-54. PubMed ID: 9717824
[TBL] [Abstract][Full Text] [Related]
11. Detection of telomerase inhibitors based on g-quadruplex ligands by a modified telomeric repeat amplification protocol assay.
Gomez D; Mergny JL; Riou JF
Cancer Res; 2002 Jun; 62(12):3365-8. PubMed ID: 12067975
[TBL] [Abstract][Full Text] [Related]
12. Telomeric repeat amplification protocol: measuring the activity of the telomerase.
Xin H
Methods Mol Biol; 2011; 735():107-11. PubMed ID: 21461815
[TBL] [Abstract][Full Text] [Related]
13. Detection of telomerase activity by the TRAP assay and its variants and alternatives.
Fajkus J
Clin Chim Acta; 2006 Sep; 371(1-2):25-31. PubMed ID: 16616059
[TBL] [Abstract][Full Text] [Related]
14. TRAP-LIG, a modified telomere repeat amplification protocol assay to quantitate telomerase inhibition by small molecules.
Reed J; Gunaratnam M; Beltran M; Reszka AP; Vilar R; Neidle S
Anal Biochem; 2008 Sep; 380(1):99-105. PubMed ID: 18534183
[TBL] [Abstract][Full Text] [Related]
15. Combined assay of CYFRA21-1, telomerase and vascular endothelial growth factor in the detection of bladder transitional cell carcinoma.
Bian W; Xu Z
Int J Urol; 2007 Feb; 14(2):108-11. PubMed ID: 17302565
[TBL] [Abstract][Full Text] [Related]
16. Real-time telomeric repeat amplification protocol using the duplex scorpion and two reverse primers system: the high sensitive and accurate method for quantification of telomerase activity.
Huang YP; Liu ZS; Tang H; Liu M; Li X
Clin Chim Acta; 2006 Oct; 372(1-2):112-9. PubMed ID: 16714009
[TBL] [Abstract][Full Text] [Related]
17. Telomerase activity in patients with transitional cell carcinoma: a preliminary study.
Rahat MA; Lahat N; Gazawi H; Resnick MB; Sova Y; Ben-Ari G; Cohen M; Stein A
Cancer; 1999 Feb; 85(4):919-24. PubMed ID: 10091771
[TBL] [Abstract][Full Text] [Related]
18. Assessment and quantification of telomerase enzyme activity.
Maritz MF; Richards LA; Mackenzie KL
Methods Mol Biol; 2013; 965():215-31. PubMed ID: 23296661
[TBL] [Abstract][Full Text] [Related]
19. Telomerase activity determined by conventional telomeric repeat amplification protocol and reverse transcriptase-polymerase chain reaction assay in ovarian lesions: a comparison of assays.
Ernst A; Okkels H; Grove A; Svarrer T; Knudsen A; Madsen PH; Krarup HB
Scand J Clin Lab Invest; 2006; 66(4):287-97. PubMed ID: 16777757
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of telomerase in canine mammary tissues by immunohistochemical analysis and a polymerase chain reaction-based enzyme-linked immunosorbent assay.
Panarese S; Brunetti B; Sarli G
J Vet Diagn Invest; 2006 Jul; 18(4):362-8. PubMed ID: 16921875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
